SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates XLRN, GSKY, GWB, VLY, NOTV; Shareholders are Encouraged to Contact the Firm
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates XLRN, GSKY, GWB, VLY, NOTV; Shareholders are Encouraged to Contact the Firm |
| [07-October-2021] |
NEW YORK, Oct. 7, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:
Acceleron Pharma Inc. (NASDAQ: XLRN) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Merck & Co., Inc. for $180.00 per share in cash. If you are an Acceleron shareholder, click here to learn more about your rights and options. GreenSky, Inc. (NASDAQ: GSKY) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to The Goldman Sachs Group, Inc. Under the terms of the merger, GreenSky shareholders will receive 0.03 shares of Goldman common stock for each share of GreenSky Class A common stock they own. If you are a GreenSky shareholder, click here to learn more about your rights and options. Great Western Bancorp, Inc. (NYSE: GWB) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to First Interstate BancSystem, Inc. Under the terms of the agreement, Great Western shareholders will receive 0.8425 shares of First Interstate Class A common stock for each Great Western share they own. Following completion of the transaction, Great Western shareholders will collectively own 43% of the combined company. If you are a Great Western shareholder,click here to learn more about your rights and options. Valley National Bancorp (NASDAQ: VLY) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Bank Leumi Le-Israel Corporation. If you are a Valley National shareholder, click here to learn more about your rights and options. Inotiv, Inc. (NASDAQ: NOTV) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Envigo RMS Holding Corp. Upon closing of the transaction, Inotiv shareholders are expected to own approximately 64% of the combined company on a fully diluted basis. If you are an Inotiv shareholder, click here to learn more about your rights and options. Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders. Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com. Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors. Attorney Advertising. Prior results do not guarantee a similar outcome. Contact Information:
SOURCE Halper Sadeh LLP | ||
Company Codes: NASDAQ-NMS:VLY, NASDAQ-NMS:GSKY, NASDAQ-NMS:NOTV, NASDAQ-NMS:XLRN, NYSE:GWB |
View original content to download multimedia:© 2021 PR Newswire. All Rights Reserved.
FDA Approves First Targeted Therapy For HER2-Low Breast Cancer
